Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity. - Mougari S; Favède V; Predella C; Reynard O; Durand S; Mazelier M; Pizzioli E; Decimo D; Bovier FT; Lapsley LM; Castagna C; Lieberman NAP; et al. (Communications biology, 2025)